Diphenylpyraline Hydrochloride
Generic Name: diphenylpyraline hydrochloride
Manufactured by GLAXOSMITHKLINE. Dosage form: CAPSULE, EXTENDED RELEASE. Route: ORAL. Active ingredients: DIPHENYLPYRALINE HYDROCHLORIDE (5MG). Application: NDA011945.
Overview
Manufactured by GLAXOSMITHKLINE. Dosage form: CAPSULE, EXTENDED RELEASE. Route: ORAL. Active ingredients: DIPHENYLPYRALINE HYDROCHLORIDE (5MG). Application: NDA011945.
Dosage
Available as capsule, extended release for oral use.
Related Medications
Ethylhexyl Methoxycinnamate, Ethylhexyl Salicylate, Homosalate, And Butyl Methoxydibenzoylmethane
ethylhexyl methoxycinnamate, ethylhexyl salicylate, homosalate, and butyl methoxydibenzoylmethane
Sunscreen Uses: Helps prevent sunburn, decreases the risk of skin cancer and early skin aging if used as directed.
Elosulfase Alfa
elosulfase alfa
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
11 DESCRIPTION Elosulfase alfa is a purified human enzyme produced by recombinant DNA technology in a Chinese hamster ovary cell line. Human N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) is a hydrolytic lysosomal glycosaminoglycan-specific enzyme that hydrolyzes sulfate from either galactose-6-sulfate or N-acetyl-galactosamine-6-sulfate on the non-reducing ends of the glycosaminoglycans keratan sulfate (KS) and chondroitin-6-sulfate (C6S).
Ansuvimab
ansuvimab
Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]
11 DESCRIPTION Ansuvimab-zykl is an Orthoebolavirus zairense (EBOV) glycoprotein 1 (GP1)-directed recombinant, human IgG1 monoclonal antibody. Ansuvimab-zykl is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology and has an approximate molecular weight of 147 kDa. EBANGA (ansuvimab-zykl) for injection is a sterile, preservative-free, off-white to white lyophilized powder in a single-dose vial for IV use after reconstitution and dilution.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.